INTRODUCTION AND OBJECTIVES: Radical cystectomy (RCE) shows the highest mortality and morbidity among urologic routine surgery. We analysed in-hospital outcomes of all RCE in Germany from 2006 to 2013 with a focus on the institutions' annual caseload and surgical approach.
INTRODUCTION AND OBJECTIVES: Radical cystectomy (RCE) shows the highest mortality and morbidity among urologic routine surgery. We analysed in-hospital outcomes of all RCE in Germany from 2006 to 2013 with a focus on the institutions' annual caseload and surgical approach.
METHODS: By using remote data processing we analysed the nationwide German hospital billing data from 2006 to 2013. All cases with a bladder cancer diagnosis combined with RCE were eligible for evaluation. We calculated mortality and transfusion rates during the hospital stay and the length of stay. The results were stratified for hospital characteristics, caseload, and the surgical approach.
RESULTS: Total annual RCE numbers increased from 5,627 in 2006 to 7,399 in 2013. The share of open surgery declined from 99.3% to 96.6%, conventional laparoscopy increased from 0.7% to 1.6%, and the robot-assisted approach from 0% to 1.8%. The patients' mean age was 68.2 AE 9.9 years. The average in-hospital mortality rate was 4.5% for open RCE; in comparison it was lower with 3.8% for laparoscopic (p¼0.35) and 2.5% for robotic RCE (p¼0.002). Hospitals with high annual caseloads >50 RCE showed lower mortality rates with 3.3% vs. 4.1% (26-50 RCE), 5.0% (11-25 RCE), 5.2% (4-10 RCE), and 7.0% (<3 RCE) (p<0.001). The need for blood transfusion during the hospital stay was higher for open with 60.0% vs. laparoscopic 50.6% vs. robotic RCE with 35.9% (p<0.0001). The mean length of stay was longer for open with 25.3 days and laparoscopic RCE with 26.0 days vs. robotic RCE with 21.4 days (p<0.0001). Hospitals with high annual caseload >50 RCE showed a shorter hospital stay with 23.3 days vs. 24.7 days (26-50 RCE), 26.1 days (11-25 RCE), 26.3 days (4-10 RCE), and 24.5 days (<3 RCE) (p<0.0001). Multivariate models indicated that the patient's age and the type of urinary diversion were the most important factors for mortality and the need for blood transfusion (p<0.0001). Also on multivariate analysis hospitals with very low annual caseload (<3 RCE) had higher mortality (p¼0.02), blood transfusion (p¼0.0004), and a longer hospital stay (p<0.0001).
CONCLUSIONS: Hospitals with high annual caseload volumes show an improved outcome with lower rates of in-hospital mortality, blood transfusion, and a shorter hospital stay. Compared to the open approach robotic RCE showed lower rates of in-hospital mortality, blood transfusion and a shorter hospital stay. Whether this result is due to selection bias warrants further examinations. The adoption of the da Vinci Surgical System (Intuitive Surgical, Inc, Sunnyvale, CA) for robotic surgery requires a substantial financial investment by hospitals, acquisition of new surgical skills by surgeons, and demand from patients. The adoption rate and factors influencing the utilization of robotic surgery in the surgical management of patients with bladder cancer is currently unclear. Our aim was to evaluate trends in surgical approach and outcomes for radical cystectomy in the United States.
METHODS: Using the Premier Healthcare Database, we captured all patients who underwent a RC (ICD-9 code 57.71) from 2003 to 2015. To identify robot-assisted (RARC) and laparoscopic RCs (LRC), we performed a detailed review of the hospital chargemaster. Multivariable regression analyses were performed after adjusting for survey weighting and clustering to evaluate factors associated with RARC use.
RESULTS: Across the study period, there were a total of 71,844 RC (58,779 ORC, 3847 LRC, 9218 RARC). There is a gradual rise in the use of RARC from 0.1% in 2003 to 33.9% in 2015), overtaking the laparoscopic approach in 2009 (15.2% vs. LRC. Major (Clavien¼3) and overall (Clavien¼1) complication rates showed a rising trend up to 19.6% and 68.7% respectively in 2011 before plateauing (Figure 1) . Factors significantly associated with RARC include older age (OR 1.01, p¼0.03), male gender (OR 1.36, p¼0.01), married (vs. non-married, OR 1.23, p¼0.02), private insurance (vs. Medicare, OR 1.34, p<0.01), East North Central division (vs. South Atlantic, OR 2.13, p¼0.03), Middle Atlantic (OR 2.99, p¼0.01), hospital volume >90th percentile (>26/yr) (vs. ¼90th percentile, OR 2.10, p¼0.03) and later time period (vs. 2003 -2006 , OR for 2007 -2010 : 7.74, OR for 2011 -2015 .99, both p<0.001). Patient with Charlson comorbidity index (CCI) ¼2 (vs. CCI 0, OR 0.71, p<0.01) and at West South Central division (OR 0.36, p¼0.04) were less likely to undergo RARC.
CONCLUSIONS: Currently, 1 in 3 RC cases are performed using robotic assistance. A variety of patient and hospital geographic characteristics appear to influence this increased utilization. This may be attributed to the acquisition of robotic surgical skills and familiarity with transperitoneal pelvic anatomy following the widespread use of robotic radical prostatectomy. METHODS: We performed a retrospective cohort study of patients who underwent cystectomy for cT2-cT4, N0 bladder cancer Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e725 between 2008 and 2013 using the National Cancer Database. Quality indicators were defined as 1) surgical margin status, 2) lymph node yield, and 3) receipt of neoadjuvant chemotherapy. Univariate analysis and multivariate analysis was used to assess the relationship between academic facility type and annual cystectomy volume and quality indicators while controlling for demographic and pathologic characteristics. RESULTS: A total of 12,083 patients met our inclusion criteria. On multivariate analysis, while controlling for demographic and pathologic characteristics, treatment at academic facilities was associated with higher rates of negative margins (OR: 0.80; 95%CI: [0.67-0.95], p¼0.01), greater lymph node yields (OR: 0.49; [0.44-0.55], p<0.001), and higher rates of neoadjuvant chemotherapy(OR: 0.73; [0.64-0.55], p<0.001). High volume facilities (>24 cystectomies/year) were associated with greater lymph node yields (OR: 2.69; [2.08-3.47], p<0.001), but not significantly associated with increased neoadjuvant chemotherapy use. Intermediate volume centers (12-24 cystectomies/year) were associated with increased neoadjuvant chemotherapy use (OR: 1.60; [1.36-1.88], p<0.001).
Source of Funding: None
CONCLUSIONS: At a national level, high quality indicators of cystectomy (negative surgical margin, adequate lymph node yields, and receipt of neoadjuvant chemotherapy) were more likely to occur at academic facilities. High volume centers were associated with higher lymph node yields. Such data support the regionalization of cystectomy care to these centers.
Source of Funding: none

MP54-11 COMPARISON OF READMISSION AND SHORT-TERM MORTALITY RATES BETWEEN DIFFERENT TYPES OF URINARY DIVERSION IN PATIENTS UNDERGOING RADICAL CYSTECTOMY
Bruno Nahar*, Tulay Koru-Sengul, Nachiketh Soodana Prakash, Vivek Venkatramani, Feng Miao, Aliyah Gauri, David Alonzo, Sanjaya Swain, Alameddine Mahmoud, Chad Ritch, Sanoj Punnen, Dipen Parekh, Mark Gonzalgo, Miami, FL INTRODUCTION AND OBJECTIVES: Radical cystectomy (RC) is a complex and morbid procedure primarily because of the urinary diversion required after bladder removal. Choosing the optimal diversion type can be challenging and depends on clinical parameters, as well as the potential morbidity related to each approach. We analyzed a large national oncology outcomes database and compared 30 day readmission rates, as well as 30 and 90 day mortality rates between different types of urinary diversion among patients undergoing RC.
METHODS: We identified patients who underwent RC for bladder cancer in the National Cancer Data Base (NCDB) from 2004 to 2013. Patients were grouped based on the type of urinary diversion performed: non-continent (ileal conduit [IC]) or two continent techniques (pouch [CP] or orthotopic neobladder [NB]). We used multivariable logistic regression models to compare 30 day unplanned readmission and 30 and 90 day mortality between the different types of urinary diversion. In order to control for residual confounding we performed a propensity score matching and repeated the analysis.
RESULTS: Among 11,933 patients who underwent RC, we identified 10,197 (85.5%) IC, 1,044 (8.7%) CP, and 692 (5.8%) NB. Patients who received IC were significantly older and had more comorbidities (p<.0001). Continent diversions were more likely to be performed at an academic center (p<.0001). In multivariate analysis, patients undergoing NB had an increased likelihood of being readmitted (OR 1.41, p¼.010), but decreased risk of dying within 90 days (OR 0.47, p¼.007). However, after propensity score matching there was no significant difference in short-term mortality within groups. Surgery performed at a non-academic center was an independent predictor of readmission within 30 days of discharge (OR: 1.19, p¼.010) and death within 30 days of surgery (OR 1.27, p¼.043).
CONCLUSIONS: Patients undergoing NB had increased rates of readmission compared to IC. Similar short-term mortality rates were observed among the different types of urinary diversion. Surgery performed at a non-academic center was associated with a higher readmission and 30-day mortality rates. INTRODUCTION AND OBJECTIVES: Sarcopenia, an objective measurement of frailty, has been associated with poor outcomes in lung, gastrointestinal, and breast cancers. We examined the relationship between sarcopenia and postoperative complications in patients undergoing radical cystectomy for bladder cancer.
Source of
METHODS: 151 patients who underwent radical cystectomy for high risk or muscle invasive bladder cancer were identified from a prospectively collected institutional database from November 2008 to April 2016. All patients had preoperative computed tomography imaging within 30 days of surgery for inclusion. Regions of interest (ROI) were drawn around the iliopsoas and erector spinae (ES) muscular compartments bilaterally, and the density was recorded as an average of measurements by a genitourinary radiologist blinded to postoperative outcome. Postoperative complications were identified as defined by the American College of Surgeons National Surgery Quality Improvement Program within a 90-day follow-up period.
RESULTS: 276 complications were identified in 114 patients (75.5%). Iliopsoas muscle density correlated moderately with ES muscle density (r 2 ¼ 0.344, p <0.001) and both iliopsoas and ES density correlated with age (r 2 ¼ 0.082, p <0.001 and r 2 ¼ 0.165, p <0.001 respectively). While no overall association was found between iliopsoas muscle density and complications, lower ES density was associated with incidence of any complication (22.2 HU vs. 30.1 HU, p ¼ 0.016) and an increased number of complications (r 2 ¼ 0.032, p ¼ 0.014). Lower iliopsoas muscle density was associated with increased incidence of wound infection (36.5 HU vs. 42.7 HU, p ¼ 0.019), whereas lower ES density was associated with the need for reoperation (12.3 HU vs. 25.2 HU, p ¼ 0.041).
CONCLUSIONS: Sarcopenia is associated with a higher incidence of postoperative complications in patients undergoing radical cystectomy for bladder cancer. Preoperative iliopsoas density and a novel measure, ES density, may be helpful to identify those patients at greater risk of major post-operative complications.
